Intensive cholesterol lowering after heart attack
Part of Heart & circulation clinical trials.
This study tests whether a stronger-than-usual cholesterol-lowering treatment right after a heart attack (STEMI or NSTEMI) can improve outcomes. It may help protect the heart by lowering harmful cholesterol quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a recent heart attack called STEMI or NSTEMI
- You agree to take part and sign informed consent
- You are not in cardiogenic shock (a life-threatening condition where the heart can’t pump enough blood)
- There is no reason you can’t take cholesterol-lowering medicines (no contraindication)
- You were not already taking cholesterol-lowering medicine when you were admitted
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving strong cholesterol-lowering medicine within 24 hours after a heart attack to see if it helps recovery. It is for people who have had a recent heart attack and are getting a stent placed.
This trial looks at when and how to use cholesterol-lowering treatment soon after a heart attack. It may help people lower LDL (“bad” cholesterol) safely in the first days after an acute event.
This trial studies how well long-term cholesterol-lowering treatment works in people who recently had a heart attack (STEMI or NSTEMI). It may help your care team understand which patients benefit most and how treatment should be continued safely.
This study tests whether starting evolocumab (a cholesterol-lowering injection) soon after a heart attack helps prevent future heart problems. You'll receive the study drug or placebo for 52 weeks while your heart is monitored with imaging scans.
This trial tests whether giving a powerful cholesterol-lowering drug (PCSK9 inhibitor) very early after a heart attack can help prevent further heart problems. It is for people who have had a recent heart attack and have blockages in more than one heart artery.
This study compares two cholesterol treatment approaches after a heart attack: a lower dose combination versus a higher dose single medicine. It aims to see which option works well and is tolerable for people after a treated heart attack.
Hear when a new ST Elevation Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.